Cancer Types


  • CAR T-cell Therapy: Understanding the Warning and the Risks

    The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?

    by Sandra Gordon

  • Living With Chronic Blood Cancer

    Thanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.

    by Kendall K. Morgan

  • Q&A

    Tangled Family Ties

    Susan Keller’s best hope at keeping cancer at bay meant tracking down a brother who didn’t want to be found.

    by Marci A. Landsmann

  • Forward Look

    Losing Heart

    Cardiovascular mortality rates for survivors of early-stage Hodgkin lymphoma outpace cancer-related mortality.

    by Marci A. Landsmann

  • Taking Stock of CAR T-Cell Therapy

    Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.

    by Kendall K. Morgan

  • Survivor Profile

    Control What You Can

    Business leader CiCi Rojas takes life lessons from lymphoma.

    by Lindsey Konkel Neabore

  • Forward Look

    CAR T Cells for Blood Cancer Patients

    Researchers aim to minimize disease relapses by targeting multiple proteins.

    by Erin O'Donnell

  • A Treatment That Came Just in Time

    Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

    by Laurie Adami

  • Searching the Blood for Signs of Altered Immunity

    The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.

    by Kate Yandell

  • Forward Look

    Medicare to Cover CAR-T Cell Therapy

    High cost may still limit access.

    by Nancy Averett